SEC Form 4 · accession 0001209191-15-050757

Alaunos Therapeutics, Inc. · TCRT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Vice Pres., Treasurer, & CAO

Period of report

Jun 3, 2015

Accepted (ET)

Jun 5, 2015 · 6:04 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001107421

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jun 3, 2015	S	26,666	$9.60	D	0	D
Common Stock	Jun 3, 2015	M	3,334	$0.80	A	3,334	D
Common Stock	Jun 3, 2015	S	3,334	$9.70	D	0	D
Common Stock	Jun 3, 2015	M	27,500	$2.30	A	27,500	D
Common Stock	Jun 3, 2015	S	27,500	$9.70	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F1	$0.80	Jun 3, 2015	M	3,334	D	—	Feb 6, 2019	Common Stock	3,334	0	D
Stock Option (right to buy)^F2	$2.30	Jun 3, 2015	M	27,500	D	—	Jun 27, 2023	Common Stock	27,500	55,000	D